BIOMARIN PHARMACEUTICAL INC - Director's Dealing 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-09-13

Reporting Person: MEIER RICHARD A (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-13	Common Stock	M	12000	$21.510	Acquired	81610	Direct
2018-09-13	Common Stock	M	3000	$21.510	Acquired	84610	Direct
2018-09-13	Common Stock	S	2800	$99.240	Disposed	81810	Direct
2018-09-13	Common Stock	S	200	$99.250	Disposed	81610	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-09-13	Stock Option (Right to buy Common Stock)	$21.51	M	3000	Disposed	2020-05-11	Common Stock (3000)	Direct
2018-09-13	Stock Option (Right to buy Common Stock)	$21.51	M	12000	Disposed	2020-05-11	Common Stock (12000)	Direct

F1: Reflects the number of options outstanding after the transactions from this specific stock option grant.